Thomas Richard Kassberg

Insider Reports History

Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Signature
/s/ William Chou, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Richard Kassberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. CBO & EVP Common Stock 265K $11.4M $42.92 Mar 3, 2025 Direct
Passage BIO, Inc. Director Employee Stock Option (right to buy) 174K Sep 30, 2024 Direct
Passage BIO, Inc. Director Director Stock Option (right to buy) 144K May 28, 2025 Direct
Ultragenyx Pharmaceutical Inc. CBO & EVP Stock Option (Right to Buy) 31.4K Mar 1, 2024 Direct

Insider Reports Filed by Thomas Richard Kassberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PASG Passage BIO, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2025 3 -$276K 4 Mar 4, 2025 CBO & EVP
PASG Passage BIO, Inc. Sep 30, 2024 1 $0 4 Oct 2, 2024 Director
PASG Passage BIO, Inc. Sep 10, 2024 0 $0 3 Oct 2, 2024 Director
RARE Ultragenyx Pharmaceutical Inc. Mar 11, 2024 1 -$575K 4 Mar 12, 2024 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 5 -$69.1K 4 Mar 5, 2024 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Oct 23, 2023 3 -$1.03M 4 Oct 24, 2023 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2023 5 -$244K 4 Mar 3, 2023 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Mar 11, 2022 1 -$689K 4 Mar 15, 2022 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2022 3 -$158K 4 Mar 3, 2022 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Dec 31, 2021 1 $0 5 Feb 1, 2022 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Oct 14, 2021 1 -$23.2K 4 Oct 18, 2021 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. Sep 30, 2021 2 $34K 4 Oct 1, 2021 CBO & EVP
RARE Ultragenyx Pharmaceutical Inc. May 6, 2021 1 -$41.3K 4 May 10, 2021 CBO & EVP